How Much Does Foundayo Cost in 2026? Self-Pay, Insurance and Medicare
Foundayo (orforglipron) has no single price. Lilly charges by dose, from $149 to $349 a month for self-pay, about $25 a month with commercial insurance that covers it, and $50 a month through the Medicare GLP-1 Bridge. Here is every published price, where each one applies, and the traps people keep hitting.
Semaglutides.org is for information only and is not medical advice. Always talk to a licensed healthcare provider about your own care. Some links to telehealth services are affiliate links, labeled where they appear.
Foundayo (orforglipron) does not have one price. It has at least four, and which one you pay depends on your dose, your insurance status, and which pharmacy route you use. That is unusual even by US drug pricing standards, and it is the single most confusing thing about the drug for new patients.
This article lays out every published price as of September 14, 2026, names the source for each, and flags the places where people are getting caught out. Prices change. Check Lilly’s own terms page before you act on anything here, and talk to a healthcare provider about whether the medicine is appropriate for you at all.
What does Foundayo cost if you pay cash?
Lilly publishes a dose-tiered self-pay price rather than a flat one. These are point prices per dose, not a range and not a savings-card tier. As of September 14, 2026 the published ladder is (verified 2026-09-14) [1]:
| Dose | Regular self-pay price | Current price |
|---|---|---|
| 0.8 mg | $149 / month | $149 |
| 2.5 mg | $199 / month | $149 through December 31, 2026 |
| 5.5 mg | $299 / month | $199 through December 31, 2026 |
| 9 mg | $299 / month | $299 |
| 14.5 mg | $349 / month | $299 with the Self-Pay Journey Program |
| 17.2 mg | $349 / month | $299 with the Self-Pay Journey Program |
Three details matter more than the numbers themselves.
The temporary cuts are time-limited and their start date is not published. Lilly’s own terms page states the 2.5 mg and 5.5 mg reductions run “for a limited time, through December 31, 2026” but does not publish a start date [1]. Patients in the r/FoundayoPill community reported the new prices appearing on September 1, 2026, some saying they received a text from LillyDirect that day, and several who had filled a day or two earlier said LillyDirect refunded the difference on request [2]. Those are consumer reports, not a stated Lilly policy. Nothing has been published about what happens on January 1, 2027.
The Journey Program has a clock. The $299 price at the two highest doses applies only if each refill is purchased within 45 days of the previous fill’s delivery. Miss that window and the regular $349 applies [1].
A “month” means 30 days. Lilly defines it that way in its terms, and taxes and fees may be added [1].
At the top dose, $299 a month works out to about $3,588 a year, or $4,188 at the regular $349 price.
What does Foundayo cost with no discount at all?
Lilly does publish a list price. It is on the company’s own price transparency site, and the wholesale acquisition cost — the price Lilly charges wholesalers, before any discount — is $649 for a 30-day supply, flat at every strength [14]. Fierce Pharma reported the same $649 figure at launch, attributing it to Lilly’s own briefing of Jefferies analysts [15], and U.S. News reports it as the list price [16].
An earlier version of this page derived a figure of $669 by adding each self-pay card price to its published maximum savings cap. That arithmetic does not hold, because a savings cap is a ceiling on the discount rather than the discount actually applied, and the derived number was $20 too high. The published $649 replaces it.
Three different numbers get called “the cash price,” and they are not interchangeable:
| Figure | Amount | What it actually is |
|---|---|---|
| List price (WAC) | $649 / 30 days | What Lilly charges wholesalers [14] |
| Retail cash price | $739.80 – $788.68 | What GoodRx reports pharmacies charge without a coupon; average $782.90 [17] |
| Reported at the register | about $650 – $700 | What individual patients said they saw before a coupon was applied [3][4] |
None of these is what most people pay, because the self-pay ladder above applies through LillyDirect, TrumpRx, retail pharmacies and telehealth alike. The $649 figure is still worth knowing for one reason: it is what appears on the receipt when a savings program is refused, which is exactly the amount one patient reported being charged when Amazon Pharmacy declined the card [8].
Foundayo is also listed on TrumpRx, the federal drug price comparison site, which displays the same Lilly ladder and hands you off to LillyDirect rather than dispensing itself. TrumpRx headlines the listing as “up to 77% off” — a discount measured against the $649 list price, which is where the $149 starting figure comes from [18].
How much is Foundayo with commercial insurance?
If your commercial drug plan covers Foundayo, Lilly’s savings card can bring your cost to as little as $25 for a one-, two- or three-month fill [1].
The caps matter. Savings are limited to $100 per one-month fill, $200 per two-month and $300 per three-month fill, with an overall annual cap of $1,000 per calendar year and a maximum of 10 fills per year [1]. If your plan’s copay is higher than $125 for a month’s supply, the card knocks $100 off and you pay the rest. The card requires US or Puerto Rico residency, age 18 or older, and a prescription consistent with the FDA-approved label, and it expires December 31, 2026 [1].
If your commercial plan does not cover Foundayo, the same card instead delivers the self-pay ladder above.
The trap worth knowing: insured is not always cheaper. One patient described a plan that “covered” Foundayo at $371 a month for the 0.8 mg dose, reduced to $271 with the savings card — against a $149 self-pay price for the same bottle [2]. That is a single self-reported case, not a survey, but the mechanism behind it is documented in Lilly’s own terms: the card caps savings at $100 per one-month fill, so it cannot close a large coinsurance gap [1]. If your plan puts Foundayo on a high coinsurance tier, running it through insurance can cost more than ignoring your insurance. Comparing both numbers before you fill is worth the five minutes.
The counterweight is that self-pay dollars do not count toward your deductible or out-of-pocket maximum, and cannot be submitted to your plan for reimbursement [1]. If you expect to hit your deductible anyway from other medical costs, that changes the math.
Which insurance plans cover Foundayo?
Foundayo launched in April 2026 without the immediate formulary position that Novo Nordisk’s Wegovy pill enjoyed, and analysts repeatedly named that as the main drag on its launch.
That changed over the following two months. Lilly announced on May 28, 2026 that all three of the largest pharmacy benefit managers would cover its full obesity portfolio [5]. CVS Caremark, the last of the big three, began covering Foundayo on its commercial template on June 1, 2026 and agreed to restore Zepbound to those templates by October 1, 2026 [6]. Lilly’s leadership told analysts that broad direct-to-consumer marketing only began after that commercial access was secured.
Coverage on a template is not the same as coverage on your plan. Employers buy from PBMs à la carte, and many still exclude weight-management drugs outright or require prior authorization with documented BMI, comorbidities and sometimes prior attempts at lifestyle change. Patient reports through mid-2026 describe both quick approvals and flat denials for people with hypertension and high cholesterol on the chart [2]. The only reliable way to know is to call the number on the back of your insurance card and ask three questions: does my policy cover GLP-1 drugs for anything besides type 2 diabetes, what exactly are the coverage requirements, and is Foundayo on my formulary.
Does Medicare cover Foundayo?
Not through normal Part D. Federal law bars Part D from covering drugs used for weight loss, which is why GLP-1s for obesity have been out of reach for Medicare beneficiaries for years.
CMS opened a workaround on July 1, 2026. The Medicare GLP-1 Bridge is a nationwide demonstration that lets eligible Part D beneficiaries get certain obesity drugs for a flat $50 monthly copay. Foundayo tablets are covered, alongside Wegovy injection and tablets and the Zepbound KwikPen [7]. The demonstration runs through December 31, 2027.
Eligibility is set by CMS, not by Lilly: age 18 or older with Part D coverage and a BMI of 35 or above, or BMI 30 or above with diastolic heart failure, uncontrolled hypertension or stage 3a or worse chronic kidney disease, or BMI 27 or above with prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease [7].
Three things trip people up. The $50 copay does not count toward your Part D deductible or the annual out-of-pocket cap. It is not reduced by Extra Help. And it cannot be spread across the year using the Medicare Prescription Payment Plan [7].
Medicare beneficiaries also cannot use Lilly’s commercial savings card. The card explicitly excludes Medicare, Medicaid, Medicare Advantage, Medigap, TRICARE, VA, DoD and state drug assistance program enrollees [1]. One patient reported Amazon Pharmacy refusing to apply the LillyDirect card specifically because they were eligible for government assistance, leaving a $649 charge on a bottle that the card would have priced at $149 or $199 depending on dose [8]. That is one person’s account, not a documented Amazon policy, but the $649 matches Lilly’s published list price for a 30-day supply exactly [14], and the exclusion it describes is written into Lilly’s published card terms [1]. If you fall into any government program, the Bridge or the self-pay route are the paths that work.
Where do you actually buy Foundayo?
LillyDirect is the channel Lilly promotes first. A prescriber sends the prescription to LillyDirect Pharmacy, one of four contracted dispensing pharmacies contacts you, savings apply automatically, and the medicine ships free to your home or can be picked up at retail. As of August 2026 the named dispensing partners are Amazon Pharmacy, Fuze Health, Gifthealth and Walmart Pharmacy [9]. Lilly also says Foundayo may be FSA or HSA eligible depending on your plan.
Disclosure: LillyDirect is owned by Eli Lilly and dispenses only Lilly products. It is a manufacturer channel, not a neutral pharmacy comparison.
Retail pharmacies. The self-pay price is not exclusive to LillyDirect. Lilly’s terms page offers an “Other Pharmacy” route, and patients have documented filling at Costco and CVS at the published prices using a Foundayo coupon generated in the GoodRx app, which carries four codes the technician has to enter correctly [3]. Several reported the till first showing the full cash price before the codes went in, and that the pharmacy needed about 24 hours to stock the tablets because they are not routinely on the shelf.
Telehealth. If you do not have a prescriber, several telehealth services will write for brand-name Foundayo. Their fee buys the consultation, not the medicine: the drug is billed separately at Lilly’s ladder, which is why every service costs more as your dose climbs. An earlier version of this page listed fees taken from a single Reddit thread. Each one below was instead read on the vendor’s own pricing page on September 14, 2026.
| Service | Published fee | What the fee covers |
|---|---|---|
| Curai Health | $29 / month unlimited, or $49 per video visit, $39 per chat visit | Consultation only [19] |
| GoodRx | $39 / month | Unlimited online care, medication not included [20] |
| Walgreens Weight Management | $49 per visit, no subscription | Consultation only [21] |
| Call-On-Doc | $60 / month or $75 one-time visit (weight-loss pharmacy-pickup plan) | Consultation only; its separate general membership is $24.99 / month or $59.99 / quarter [22] |
| Ro (Ro Body) | $39 first month, then $149 / month, or $74 / month prepaid annually | Membership only; Ro sells the medicine at Lilly’s ladder [23] |
| Hers | $39 first month, then $149 / month | Membership, medication not included [24] |
Two names that circulated in the same Reddit thread are deliberately left out of the table. Lavender Sky Health was reported at “about $65 to start,” but its own pricing page could not be retrieved and its indexed text lists Foundayo at $299 to $699 a month, which is inconsistent with both the $65 figure and Lilly’s published ladder. Form Telehealth could not be identified as a trading company at all, and no fee was ever claimed for it. Neither belongs in a price comparison until someone can read the vendor’s own page.
No service above is recommended over another and the table is ordered by fee, not by preference. The two cheapest routes involve no vendor at all: your own primary care provider, or a telehealth service your insurance already covers. Neither adds a membership fee. Telehealth pricing changes often and varies by state — check the current terms yourself before acting on any of it [11].
The cheapest route for most people is the one with no middleman fee at all: your own primary care provider writing the prescription, with the drug filled at the self-pay price or through insurance.
How does Foundayo’s price compare with other GLP-1s?
At the bottom of the dose ladder, Foundayo is meaningfully cheaper than injectables on self-pay. At the top, the gap narrows. And for people with good commercial coverage or Medicare Bridge eligibility, the drugs cost the same as each other, because the copay structures converge: roughly $25 a month with commercial coverage from either Lilly or Novo Nordisk, and $50 a month under the Bridge regardless of which of the covered drugs you take [1][7].
That is why cost alone rarely decides between them. What tends to decide it is coverage on your specific plan, how your body tolerates the drug, and whether you would rather take a daily pill or a weekly injection.
One real-world pattern is worth naming, because it shows up constantly in patient discussion: people switching from high-dose Zepbound to Foundayo specifically because their out-of-pocket cost on the injectable became unsustainable or their prior authorization was denied [12]. That is a financial decision with clinical consequences, and the trials do not tell you that switching preserves your results at every starting dose. It is a conversation for a prescriber, not a spreadsheet.
What might change?
Four things are dated and will move:
- The temporary 2.5 mg and 5.5 mg self-pay reductions expire December 31, 2026 [1].
- Lilly’s commercial savings card expires December 31, 2026 [1].
- The Medicare GLP-1 Bridge demonstration ends December 31, 2027 [7].
- Foundayo is not yet FDA-approved for type 2 diabetes in the US; Lilly filed in the second quarter of 2026. An approval there would change formulary placement, because diabetes coverage works very differently from obesity coverage.
Prices in this space have moved several times a year since 2024. Treat any figure you read, including these, as a snapshot with a date attached.
Nothing here is advice about whether to take Foundayo, at what dose, or whether to switch from another medicine. Those decisions belong to you and a healthcare provider; this page only describes what the manufacturer, CMS and insurers have published about price.
Sources
- Foundayo coverage and savings terms — Eli Lilly and Company
- New Foundayo pricing discussion — r/FoundayoPill, September 2, 2026
- Filling Foundayo at Costco with a GoodRx coupon — r/FoundayoPill, April 16, 2026
- Foundayo 0.8 mg prescription cost report — r/FoundayoPill, August 7, 2026
- Foundayo and Zepbound Now Covered for Millions of Americans — Eli Lilly, May 28, 2026
- CVS Caremark expands GLP-1 weight management coverage — CVS Health
- Medicare GLP-1 Bridge — Centers for Medicare & Medicaid Services
- Savings card refused for a government-assistance-eligible patient — r/FoundayoPill, May 23, 2026
- LillyDirect: Foundayo — Eli Lilly and Company
- First time taking Foundayo: pricing routes — r/FoundayoPill, September 9, 2026
- Telehealth recommendations for Foundayo — r/FoundayoPill, September 7, 2026
- Switched from Zepbound 15 mg to Foundayo 17.2 mg — r/FoundayoPill, July 29, 2026
- FOUNDAYO US Prescribing Information, revised 7/2026 — Eli Lilly and Company
- Foundayo cost information: list price (WAC) — Lilly Pricing Info, Eli Lilly and Company
- Analysts pin high hopes early on Lilly’s Foundayo launch — Fierce Pharma
- Foundayo (orforglipron) for weight loss: cost, side effects, results — U.S. News & World Report
- Foundayo prices and coupons — GoodRx
- Foundayo on TrumpRx — TrumpRx
- Improving weight: visit pricing — Curai Health
- Get Foundayo online — GoodRx
- Get the Foundayo pill for weight loss online — Walgreens
- Weight loss plans and subscribe and save plans — Call-On-Doc
- Weight loss program pricing — Ro
- Foundayo pill — Hers
Questions people ask
How much does Foundayo cost per month?
It depends on the dose and how you pay. Lilly's published self-pay prices run $149 a month for the 0.8 mg dose up to $349 for the two highest doses, with temporary reductions through December 31, 2026. With commercial insurance that covers Foundayo, Lilly's savings card can bring the copay to as little as $25. Through the Medicare GLP-1 Bridge it is a flat $50.
How much is Foundayo without insurance?
Lilly's self-pay ladder is the answer for most people: $149 for 0.8 mg, $149 for 2.5 mg and $199 for 5.5 mg through December 31, 2026, $299 for 9 mg, and $299 for the two top doses if you refill within 45 days. Without any savings program at all, Lilly's published list price is $649 for a 30-day supply, and GoodRx reports retail cash prices averaging $782.90.
Is Foundayo covered by insurance?
Increasingly, yes, but not universally. All three of the largest pharmacy benefit managers agreed in May 2026 to cover Lilly's obesity portfolio, and CVS Caremark added Foundayo to its commercial templates on June 1, 2026. Many plans still require prior authorization, and some employer plans exclude weight-management drugs entirely.
Does Medicare cover Foundayo?
Not as a normal Part D benefit, because federal law bars Part D from covering drugs used for weight loss. CMS launched the Medicare GLP-1 Bridge on July 1, 2026, a demonstration that covers Foundayo and several other obesity drugs at a flat $50 monthly copay for eligible beneficiaries through December 31, 2027.
Is Foundayo cheaper than Zepbound or Wegovy?
At the low end of the dose ladder, usually yes on self-pay. At the top doses the gap narrows a lot. Both Lilly and Novo Nordisk advertise about $25 a month for eligible commercially insured patients, and both are $50 under the Medicare GLP-1 Bridge, so for many people the price is the same regardless of which drug.
Can I use the Lilly savings card with Medicare?
No. Lilly's commercial savings card excludes anyone enrolled in Medicare, Medicaid, Medicare Advantage, Medigap, TRICARE, VA, DoD or a state drug assistance program. People in those programs use the Medicare GLP-1 Bridge or pay self-pay prices instead.
Where do you buy Foundayo at the self-pay price?
LillyDirect is the channel Lilly promotes, and it applies savings automatically and ships free. The same self-pay pricing is also available at retail pharmacies through Lilly's Other Pharmacy route, and patients have reported filling at Costco, CVS, Walmart and Amazon Pharmacy at the published prices.
Does the self-pay price count toward my deductible?
No. Lilly's terms say self-pay dollars do not count toward an insurance deductible or out-of-pocket maximum, and cannot be submitted to a plan for reimbursement. That matters if you expect to hit your deductible from other medical costs during the year.
This article summarizes FDA labeling, published research and company information current as of September 14, 2026. It is not medical advice and does not replace a conversation with your own healthcare provider. How we research and verify.